ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

YDES vs XGN // EV/EBITDA & P/E VALUATION

YD Bio Limited (NASDAQ) VS. Exagen Inc. (NASDAQ) • 15-METRIC TALLY: YDES 4 — XGN 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (YDES VS. XGN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC YDES XGN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 28.10% 58.30% -30.20 XGN /gross-margins <GO>
Return on Invested Capital (ROIC) -20.00% -35.00% +15.00 YDES /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -1.93% -6.77% +4.84 YDES /fcf-yield <GO>
Operating Margin -60.00% -21.10% -38.90 XGN /operating-margins <GO>
Net Profit Margin -60.00% -30.00% -30.00 XGN /net-margins <GO>
Revenue Growth (YoY) 16.90% 19.70% -2.80 XGN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 13.44 0.20 +13.24 YDES /balance-sheet <GO>
Piotroski F-Score Quality 4/9 4/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.3 58.6 -6.29 XGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $415.8M $210.8M $205.0M YDES /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR YDES REV XGN REV YDES GROSS % XGN GROSS % YDES FCF XGN FCF
FY 2025 $596.8K $66.6M 28.1% 58.3% -$8.0M -$14.3M
FY 2024 $510.4K $55.6M 30.4% 59.5% -$1.3M -$13.8M
FY 2023 $350.1K $52.5M — — -$55.7K -$14.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
YDES // BETA —
XGN // BETA —